Evidence map›Paper›PMID 14685761›Full record

ArticleWorld journal of urology2004

Predictive medicine in urology.

Bernd J Schmitz-Dräger, Nuria Malats, Pierfrancesco Bassi

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in World journal of urology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bernd J Schmitz-Dräger
Nuria Malats
Pierfrancesco Bassi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Facing the limitations of financial resources available for health services, the necessity of evaluating new strategies in health management becomes evident. Experience from non-urological diseases suggests that prevention not only can reduce the number of incidences but also can be cost-effective. Predictive medicine or modern risk assessment could be a powerful tool to determine a given individual's risk for eventually developing the disease. A significant reduction in disease-related mortality as well as a reduction in costs can be expected if prevention and screening are focused on individuals at risk.

Indexed as

HumansMass ScreeningPreventive MedicineRisk AssessmentUrologic Neoplasms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.